All episodes
Prevalence and Correlates of Past-year Kratom Use Among US Adults: Findings From the 2021–2023 National Survey on Drug Use and Health
Episode Rewind | Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service
Episode Rewind | Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
Medication Approaches for Patients With Opioid Use Disorders: Differences Between Primary Care Clinics and Specialty Addiction Treatment Programs
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine
The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder
Special Episode: A Discussion on the Emerging Concept of Fetal Fentanyl Syndrome
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review
Episode Rewind | Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem
Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings
Characterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA
Episode Rewind | From Submission to Success: Insider Tips for Getting Your Addiction Content Published
Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders
Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
Non-medical Mephentermine Use: A Systematic Review of Literature
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs
Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem
Post Void Residuals: Medications for Opioid Use Disorder, Patient Outcomes, and How Not to Get Fooled by Urine Toxicology Results
The First 100 Days: The Trump Administration and Changes to Addiction Policy
From Submission to Success: Insider Tips for Getting Your Addiction Content Published
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis
Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine
Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers
Integration of a Community Opioid Treatment Program Into a Federally Qualified Health Center
Expert Panel Consensus of the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders
The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Hospital Initiatives to Transition SUD Patients from Acute Care to Community-based Services
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022
Exploring the Impact of Opioid Settlements on Addiction Medicine
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department
Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study
Meet New JAM Editor-in-Chief, David A. Fiellin, MD, FASAM
Surveillance System for Opioid-Associated Amnestic Syndrome
HIV Preexposure Prophylaxis by Buprenorphine Prescribers
Racial-ethnic Differences in Misuse of Prescription Medications
Rejection of Referrals Based on Substance Use Diagnosis and Treatment
Patient-Centeredness of Addiction Treatment Intake
Sex Differences Among Adults With Opioid Use Disorder
Avoiding NICU for Newborns With Neonatal Opioid Withdrawal Syndrome
Computerized CBT for Substance Use Disorders
Opioid Overdose in the Hospital Setting: A Systematic Review
Integrating Reproductive Health Services into Opioid Treatment Facilities
Technology Use Among Patients in Inpatient Medically Managed Withdrawal
Opioid Agonist Treatment in Postpartum Period During Incarceration
Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs
Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)
Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients
Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios
Buprenorphine Treatment for Adolescents and Young Adults
Nicotine Content in E-cigarette liquid: often not as labeled
Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal
Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles
Improving Opioid Addiction Treatment for Pregnant Women
Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder
The Unexpected Urine Test: A Matter Far From Simple
Post-Cesarean Analgesia in Women on opioid agonists to treat Opiate Use Disorder